Tecfidera

1 Story

Sofa-Treating Chemical Reborn as Major MS Drug

Analyst predicts $1.7B in Tecfidera sales by 2015

(Newser) - As a sofa-treating agent, dimethyl fumarate gave people blisters and rashes, but now it's getting a second chance—as a much ballyhooed multiple sclerosis drug called Tecfidera, whose sales could be enormous. Among doctors, there's "a strong consensus that Tecfidera offers a more favorable clinical profile than...

1 Story